SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study

Launched by HELIO TEDESCO SILVA JUNIOR · Jul 30, 2020

Keywords

ClinConnect Summary

This clinical trial is looking at how COVID-19 affects people who have received kidney transplants. Since kidney transplant recipients take medications that weaken their immune system to prevent rejection of the new organ, researchers want to understand if they experience COVID-19 differently than the general population. The study aims to gather information about patients' backgrounds, their health conditions, and the outcomes of COVID-19 infections specifically in kidney transplant recipients.

To participate in this study, individuals must be kidney transplant recipients—this includes those who may have received multiple organ transplants—and should have tested positive for COVID-19. Both adults and children can be included, whether they are receiving treatment at home or in a hospital. Participants will have their health monitored, and the findings from this trial will help improve understanding and care for kidney transplant patients dealing with COVID-19.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Kidney transplant recipients, which may be multi-organ recipients, transplanted in any follow-up period;
• • 2. Positive diagnostic test for COVID-19 (detection of viral load, test for detection of antigens or tests for detection of antibodies);
• • 3. Outpatient or hospital management;
• • 4. Adults and children.
• Exclusion Criteria:
• • -